C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 319/20 (2006.01)
Patent
CA 2652800
The present invention provides methods for preparing a compound of formula D having activity as dopamine autoreceptor agonist and partial agonists at the postsynaptic dopamine D2 receptor. This compound is useful for treating dopaminergic disorders, such as schizophrenia, schizoaffective disorder, Parkinson's disease, Tourette's syndrome, hyperprolactinemia and drug addiction. (Formula I).
La présente invention concerne des procédés destinés à la préparation de composés dotés d'une activité d'agonistes auto-récepteurs et d'agonistes partiels de la dopamine au niveau du récepteur postsynaptique D<SUB>2</SUB> de la dopamine. Ces composés se révèlent utiles pour le traitement de troubles dopaminergiques, tels que la schizophrénie, le trouble schizo-affectif, la maladie de Parkinson, le syndrome de Tourette, l'hyperprolactinémie, et la toxicomanie.
Torys Llp
Wyeth
LandOfFree
Oxindoledioxans, synthesis thereof, and intermediates thereto does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxindoledioxans, synthesis thereof, and intermediates thereto, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxindoledioxans, synthesis thereof, and intermediates thereto will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1812017